Will 2020 Be An Exciting And Transformative Year For Syndax Pharma (SNDX)?

Syndax Pharmaceuticals Inc. (SNDX), a clinical-stage biopharmaceutical company developing cancer therapies, has a number of data readouts lined up for this year. The Company's stock has gained nearly 28 percent in just 5 trading days.

from RTT - Biotech https://ift.tt/2wuqJPb
via IFTTT